| 000 | 01771 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513183859.0 | ||
| 264 | 0 | _c19990624 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0002-9165 | ||
| 024 | 7 |
_a10.1093/ajcn/69.6.1108 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHill, J O | |
| 245 | 0 | 0 |
_aOrlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. _h[electronic resource] |
| 260 |
_bThe American journal of clinical nutrition _cJun 1999 |
||
| 300 |
_a1108-16 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Obesity Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBehavior Therapy |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aDietary Fats _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactones _xadministration & dosage |
| 650 | 0 | 4 |
_aLipase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aObesity _xdiet therapy |
| 650 | 0 | 4 | _aOrlistat |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aHauptman, J | |
| 700 | 1 | _aAnderson, J W | |
| 700 | 1 | _aFujioka, K | |
| 700 | 1 | _aO'Neil, P M | |
| 700 | 1 | _aSmith, D K | |
| 700 | 1 | _aZavoral, J H | |
| 700 | 1 | _aAronne, L J | |
| 773 | 0 |
_tThe American journal of clinical nutrition _gvol. 69 _gno. 6 _gp. 1108-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ajcn/69.6.1108 _zAvailable from publisher's website |
| 999 |
_c10316342 _d10316342 |
||